
ALC.6 | A041501
NCT03150693
ALC.6
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
Status:
Recruiting

III
Phase

1st
Line of Therapy

Early Cancer
Disease Stage

Biomarker(s)
N/A
Investigational
Product
Inotuzumab Ozogamicin
Antibody‒Drug Conjugate (i.v.)
Treatment Arms
o Experimental: Arm II (frontline chemotherapy, inotuzumab ozogamicin)
o Active Comparator: Arm I (frontline chemotherapy)